HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role for Vascular Factors in Long-Term Outcomes After Transcatheter Aortic Valve Implantation.

Abstract
Despite major technological advances, 1-year morbi-mortality after transcatheter aortic valve implantation (TAVI) is still high. Further outcome improvements may be obtained provided proper identification of prognostic factors. A change of prognostic value over time should be the hallmark of an outcome-implicated factor. In 1,425 patients treated by TAVI, the examined prognostic factors were: demographic factors and co-morbidities (age, male gender, glomerular filtration rate, and chronic obstructive pulmonary disease), cardiac function (left ventricular ejection fraction, pulmonary pressure, aortic gradient, dyspnea, and mitral regurgitation), and vascular factors (coronary artery disease, peripheral vascular disease (PVD), previous stroke, and thoracic aortic calcium-TAC-as assessed by CT scan). Cox models were used to analyze cardiovascular and all-cause mortalities over 3 years of follow-up. The time-dependent effects of the factors were analyzed using the distribution of Schoenfeld residuals. During the study period, 375 (26.3%) deaths occurred of whom 248 (17.4%) from cardiovascular causes. Only 2 factors associated with cardiovascular or all-cause mortality showed significant changes over time: dyspnea and PVD. The effect of dyspnea on cardiovascular mortality decreased over time (first- and third-year hazard ratios [95% confidence intervals]: 1.47 [1.10; 1.96] and 0.94 [0.55; 1.63], respectively), whereas the effect of PVD increased (first- and third-year hazard ratios: 0.87 [0.56; 1.35] and 2.58 [1.25; 5.33], respectively). TAC had a stable effect. In conclusion, the detrimental effects of vascular factors remained stable (TAC) or increased (PVD) over time. These factors should be targeted by specific measures to improve post-TAVI outcomes.
AuthorsClément Bècle, Benjamin Riche, Muriel Rabilloud, Géraud Souteyrand, Hélène Eltchaninoff, Thierry Lefèvre, Brahim Harbaoui, Pierre Lantelme
JournalThe American journal of cardiology (Am J Cardiol) Vol. 125 Issue 12 Pg. 1884-1889 (06 15 2020) ISSN: 1879-1913 [Electronic] United States
PMID32317099 (Publication Type: Journal Article, Multicenter Study)
CopyrightCopyright © 2020 Elsevier Inc. All rights reserved.
Topics
  • Adult
  • Aged
  • Cardiovascular Diseases (complications, mortality)
  • Female
  • France
  • Glomerular Filtration Rate
  • Heart Diseases (complications)
  • Humans
  • Male
  • Middle Aged
  • Postoperative Complications (mortality)
  • Pulmonary Disease, Chronic Obstructive (complications)
  • Risk Factors
  • Sex Factors
  • Transcatheter Aortic Valve Replacement (adverse effects, mortality)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: